Rotherham Nicotine replacement therapy voucher scheme: options appraisal
|
|
- Griselda Robinson
- 7 years ago
- Views:
Transcription
1 Rotherham Nicotine replacement therapy voucher scheme: options appraisal Board Meeting 16 July 2012 Author(s)/Presenter and title Sponsor Director Alison Iliff, Public Health Specialist, NHS Rotherham John Radford, Director of Public Health, NHS Rotherham Purpose of Paper To seek approval from the NHS SYB Board to amend the free nicotine replacement therapy (NRT) voucher scheme in Rotherham. This proposal is supported by Rotherham Metropolitan Borough Council. The paper has previously been to the Rotherham Clinical Commissioning Group Committee for information. Key Messages/Issues The current NRT vouchers scheme is overspent and rising costs are unsustainable. This paper explores the issues and offers some solutions for ongoing management based on the evidence of what works and sustainability of the service. Recommendations That the Board approve Option 4: reduce the offer to a single type of NRT per voucher (transdermal NRT patch). That the Board note that a full range of NRT treatments continue to be available via FP10. Background (Brief Summary) The current nicotine replacement therapy (NRT) voucher scheme provides 12 weeks free NRT to people quitting with the Stop Smoking Service, pharmacies or dentists. The scheme is time consuming to administer, expensive to provide, and costs are increasing with increasing numbers of quitters and product range. There has been a history of over-prescribing and waste (returns of unused products to pharmacies) in pursuit of higher quit targets. 1
2 The benefits of quitting are only realised when somebody quits on a long-term basis. The Rotherham Stop Smoking Service currently estimates 20% of its 4-week quitters are still non-smokers at one year. This would equate to about 550 people quitting long-term with NHS support in Rotherham, of which c400 would have had access to the NRT voucher scheme. For those entitled to free prescriptions NRT or other stop smoking products are available free of charge via a GP prescription. NRT is available through patients GPs subject to prescription charges or is available over the counter in pharmacies. The main advantage of operating an NRT voucher scheme is patient convenience cutting out the need to go to the GP for a prescription; this was thought to increase quit rates. This is the final year of NHS 4 week quitter targets; the New Public Health Outcome Framework uses population prevalence as a measure of tobacco control. The overall strategy for tobacco control and the method and scale of provision of stop smoking services is under review across South Yorkshire in partnership with SCHARR. The clinical evidence base for the success of Nicotine Replacement Patches is clear, however this clear choice of market leading delivery mechanism is increasingly being eroded by a choice of more complex delivery modes and drug therapy all at an increased cost and all heavily marketed by pharmaceutical companies. Analysis of Risks The risks of each option are given alongside its description. Equality Impact: Currently the voucher scheme is only offered to people quitting with the NHS Stop Smoking Service, with a pharmacy or dentist. Those quitting with general practice support must obtain their NRT via a prescription or by purchasing the products over the counter. 2
3 Rotherham Nicotine replacement therapy voucher scheme: proposal to alter the scheme Board Meeting 16 July NHS Rotherham currently runs a nicotine replacement therapy (NRT) voucher scheme for people who are attempting to quit smoking with NHS support from the Rotherham NHS Stop Smoking Service (RSSS), pharmacies or dental practices that provide the enhanced service for stop smoking support. People who quit with support from their GP practice through the enhanced service do not have access to vouchers. Vouchers are only provided for people who are registered with a Rotherham GP. 2. NRT vouchers are issued to provide twelve weeks supply of a specified range of NRT products free of charge to people trying to quit smoking through RSSS, pharmacies or dentists. Each voucher covers a two week supply and is completed by the stop smoking advisor in consultation with the person quitting. Each person can be given whatever NRT products needed to complete their quit attempt. 3. An agreement is in place with some pharmacies for redeeming the vouchers. The pharmacy is paid for the cost of the products supplied plus a dispensing fee. 4. The budget for the NRT voucher scheme has been increasing as the number of people making quit attempts has increased, and in 11/12 was significantly overspent. The cost of fulfilling each voucher is increasing as new and more expensive products come onto the market; the average voucher cost rose by 1.00 between the first and last six months of the year in 11/12. When over 11,000 vouchers are issued each six months this apparently small increase has a significant impact on budget. 250,000 is in the budget line for the NRT voucher scheme in New research published in the British Medical Journal in March 2012 showed that offering free NRT in addition to standard care on the NHS quitline does not improve quit rates (BMJ 2012;344:e1696). This would appear to be borne out by the local data (Table 1), which shows minimal difference in quit rates between the stop smoking service and pharmacies, which issue free NRT, and GP settings, which don t. For patients attending GP practices to stop smoking, issuing an FP 10 acts like a voucher. The Rotherham Quit Smoking service is increasingly offering a quitline type service as a cost effective method of quit support. 3
4 Table 1: Quit rates by intervention setting (source: DH quarterly return data) Quit rate GP setting 51% Stop Smoking 49% Service Pharmacy 45% Q1-Q3 GP setting 49% Stop Smoking 52% Service Pharmacy 46% 6. We propose six options for continued management of the NRT voucher scheme for the Board to consider: Option 1: withdraw the scheme in its entirety. This option would involve discontinuing the NRT voucher scheme in a managed process over the next 3-4 months. The current agreement with the pharmacies that fulfil the vouchers would require three months notice to be given to discontinue the scheme, which would also allow us time to notify all the advisors on the local enhanced service and the specialist service that they should stop issuing vouchers for new quit attempts and enable pharmacies to run down stock levels. Anybody who has started a quit attempt with the offer of free NRT would continue to receive the vouchers until their quit attempt ceased. Pharmacies make little, if any, profit on this scheme and would be able to increase over the counter sales if free supplies are no longer offered. Risks: this original proposal has been vigorously opposed by the local Stop Smoking Service, who have lobbied local politicians and the media, and have sought support for their arguments from the authors of the BMJ article. Continuing to pursue a complete withdrawal of the scheme could therefore bring some reputational risk to NHS Rotherham and RMBC. There may be reduced access to the specialist service and a reduction in their quit rates if quitters switch to General Practice provision. Advantages: frees up substantial financial resource for other tobacco control measures. Option 2: continue the scheme as is We make no changes to the voucher scheme and continue to offer 12 weeks free NRT to all those making a quit attempt. Risks: The existing scheme is financially unsustainable given increasing quit attempts and increasing product cost. The average voucher value in the second six months of the year was 1 higher than in the first; if this were replicated throughout 12/13 the budget would again be overspent, even with no additional quit attempts. 4
5 Option 3: introduce a prescription charge per item for those people who do not have access to free prescriptions This arrangement was in place when the voucher scheme was developed. However, the majority of those making a quit attempt were entitled to free prescriptions and as a result of the few paid-for vouchers errors frequently occurred in pharmacy and in the processing of the vouchers. Risks: The impact on spend would be minimal and create an additional administrative burden. Option 4: reduce the offer to a single type of NRT per voucher (transdermal patch) Most vouchers are dispensed for a long-acting form of NRT (a patch) and a shortacting product. If only patches were offered free a significant saving on the budget could be made. In 11/12 the spend on patches was and 21, on the associated dispensing costs. If only patches had been provided in 11/12 the spend would have been within the budgeted amount. Reducing the offer to a single item would nearly halve the current spend. Risks: People attempting to quit would be asked to purchase or be directed to their GP practice for any additional NRT products required to help overcome cravings. This could still result in some negative press as is the case when any free service is restricted/reduced. Option 5: reduce the offer of free NRT to eight weeks and a reduced range of products This would enable individuals making a quit attempt to continue to access long and short-acting NRT but for a reduced time period. Over the 12-week NRT programme offered in 11/12 23,000 items were dispensed. By reducing the offer to eight weeks, we could expect around 15,350 items to be dispensed at a cost of 171,306 (based on the average voucher cost Oct-Mar). Dispensing costs would be approximately 25,020. We would also ensure that only the cheapest products in each format are offered (for example, there are price differences between some patches/gum of equivalent strength and pack size). Risks: this option would appear to offer the least risks, but could still result in some negative press due to the reduced length of provision. For options 2-5 we would also advocate transferring the budget to the Rotherham Stop Smoking Service (RSSS) and for the service to manage the prescribing within the allocated budget, giving them a greater sense of responsibility for appropriate prescribing. It would be RSSS s responsibility to establish a new scheme in line with a service specification and to deliver within budget. Reducing wastage by changing to a weekly voucher and reducing dispensing charges by establishing a direct supply could also improve the efficient management of the scheme. Any scheme would also have to be made available to stop smoking advisors within pharmacies and dentists who are not prescribers. RSSS would also have to establish and performance manage agreements with community pharmacies for the fulfilling of the vouchers. Their existing IT system has the facility to manage a voucher scheme. 5
6 The preferred options are option 4 or option 5. Option 4 would create a greater saving; option 5 offers the least change from the current system and would therefore appear the least controversial. We would recommend Option weeks is the recommended length of treatment to achieve long term quitters and hence reduce prevalence. 7. Savings made through the alteration of the scheme would free up the funding for other Public Health priorities where there is better evidence of effectiveness. In 2012/2013 there would only a part-year effect in the savings due to the winding down period. 8. References Ferguson et al Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJ 2012;344:e Alison Iliff Public Health Specialist, NHS Rotherham July
Pharmacists improving care in care homes
The Royal Pharmaceutical Society believes that better utilisation of pharmacists skills in care homes will bring significant benefits to care home residents, care homes providers and the NHS. Introduction
More informationStatistics on NHS Stop Smoking Services in England
Statistics on NHS Stop Smoking Services in England April 2013 to December 2013 Published 24 April 2014 This product may be of interest to members of the public and stakeholders to enable them to make local
More informationAdvice re Nurses Becoming Quit Card Providers
Advice re Nurses Becoming Quit Card Providers The New Zealand Nurses Organisation (NZNO) and the Nursing Council of New Zealand (NCNZ) support major health initiatives to reduce smoking in Aotearoa New
More informationARRANGEMENTS FOR THE FUTURE SUPPLY AND REIMBURSEMENT OF GENERIC MEDICINES FOR NHS SCOTLAND. Consultation Document
ARRANGEMENTS FOR THE FUTURE SUPPLY AND REIMBURSEMENT OF GENERIC MEDICINES FOR NHS SCOTLAND Consultation Document Scottish Executive Health Department October 2003 Arrangements For The Future Supply And
More informationQuality summary report: Stop Smoking Service
Quality summary report: Stop Smoking Service CLCH Quality Report Jan Dec 2011 Service exact name CLCH Stop Smoking Services (Barnet, Kensington & Chelsea, Westminster) Address line 1 Address line 2 Town/city
More informationPatient information. How to Stop Smoking Before your Operation PIF 734 V5
Patient information How to Stop Smoking Before your Operation PIF 734 V5 Fag Ends can help you stop smoking before your operation. To contact Fag Ends for help to stop smoking please call Freephone: 0800
More informationEX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH
EX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH Introduction 1. This note describes the Department of Health s (DH) ex gratia and time-limited
More informationBUSINESS CONTINUITY MANAGEMENT POLICY
BUSINESS CONTINUITY MANAGEMENT POLICY AUTHORISED BY: DATE: Andy Buck Chief Executive March 2011 Ratifying Committee: NHS Rotherham Board Date Agreed: Issue No: NEXT REVIEW DATE: 2013 1 Lead Director John
More informationSmoking cessation guidelines for health professionals: an update
Thorax 2000;55:987 999 987 Smoking cessation update Smoking cessation guidelines for health professionals: an update Robert West, Ann McNeill, Martin Raw Professor of Psychology, St George s Hospital Medical
More informationEPS Schedule 2 & 3 Controlled Drugs Requirements
EPS Schedule 2 & 3 Controlled Drugs Requirements Document Filename: EPS Ch23 CD Requirements.docx Directorate / Programme: EPS Programme Project: Electronic Prescription Service Document Reference: EPS-Sch23CD-Requirements
More informationLocal Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy
Local Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy Contents: 1. Introduction and purpose 2. Period of Service 3. Aim of the Service
More informationHOW TO STOP SMOKING. Dr Coral Gartner UQ Centre for Clinical Research
HOW TO STOP SMOKING Dr Coral Gartner UQ Centre for Clinical Research ACKNOWLEDGEMENTS SOME TRUTHS There is no magic bullet Secret to successful quitting: keep trying make every quit attempt count Every
More informationQuit plan. Your free guide on how to stop smoking. www.want2stop.info
Quit plan Your free guide on how to stop smoking www.want2stop.info Thinking? about stopping Around three quarters of those people in Northern Ireland who smoke say they would like to stop. If you are
More informationPRESCRIBING FOR SMOKING CESSATION. (Adapted from the Self-Limiting Conditions Independent Study Program for Manitoba Pharmacists)
PRESCRIBING FOR SMOKING CESSATION (Adapted from the Self-Limiting Conditions Independent Study Program for Manitoba Pharmacists) Acknowledgements The Self-Limiting Conditions Independent Study Program
More informationHealth Products and Food Branch. www.hc-sc.gc.ca
Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration
More informationMedicines to help you stop smoking
Medicines to help you stop smoking The best thing you can do for your health is to stop smoking There is no safe number of cigarettes to smoke Brain: Stroke Eyes: Macular Degeneration Skin: Ageing Wrinkles
More informationE-cigarettes: a new foundation for evidence-based policy and practice
E-cigarettes: a new foundation for evidence-based policy and practice Introduction Smoking rates in England are in long-term decline. However, tobacco use remains one of the country s major public health
More informationOn-line training in support of smoking cessation
On-line training in support of smoking cessation Jenny Bergin, Australia Slide 1 Online training for pharmacists and pharmacy assistants in support of smoking-cessation J. Bergin, S. Barnet, T. Shaw Pilot
More informationBetter Living with Obstructive Pulmonary Disease A Patient Guide
Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health The State of Queensland (Queensland Health) and The Australian Lung Foundation 2012 a Better
More informationThe Huge Burden of Smoking
Introduction Your local Stop Smoking Service Background on smoking How to offer Very Brief Advice Smoking in pregnancy How to refer to the Stop Smoking Service The Huge Burden of Smoking 10 million adults
More informationNational Standard for Tobacco Cessation Support Programme
National Standard for Tobacco Cessation Support Programme STANDARDS DOCUMENT The development of a National Standard for Intensive Tobacco Cessation Support Services is one of the key priorities of the
More informationEast & South East England Specialist Pharmacy Services Medicines Use and Safety Division Community Health Services Transcribing
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Division Community Health ervices Transcribing Guidance to support the
More informationNHS Kirklees Complaints, PALS and Claims and FOI Annual Report for the reporting period 1 April 2011 to 31 March 2012
NHS Kirklees Complaints, PALS and Claims and FOI Annual Report for the reporting period 1 April 2011 to 31 March 2012 Customer Liaison Service (PALs) Complaints 1. Introduction This report will provide
More informationSmoking and Rheumatoid Arthritis: how to deliver brief smoking cessation advice
Smoking and Rheumatoid Arthritis: how to deliver brief smoking cessation advice Offering brief advice to stop smoking is the most cost-effective and clinically proven preventative action a healthcare professional
More information4. Does your PCT provide structured education programmes for people with type 2 diabetes?
PCT Prescribing Report Drugs used in Type 2 Diabetes Discussion Points 1. Does your PCT have a strategy for prevention of type 2 diabetes? Does your PCT provide the sort of intensive multifactorial lifestyle
More informationElectronic Prescription Service. Guidance for community pharmacy contractors on implementing Release 1
Electronic Prescription Service The Electronic Prescription Service Guidance for community pharmacy contractors on implementing Release 1 Contents With about 1.3 million prescriptions now being issued
More informationHelping People to Stop Smoking
The New Zealand Guidelines for Helping People to Stop Smoking Tobacco smoking is a major public health problem in New Zealand. Around 5000 New Zealanders die each year from a smoking-related disease. Of
More informationPharmaCare is BC s public drug insurance program that assists BC residents in paying for eligible prescription drugs and designated medical supplies.
PHARMANET AND PHARMACARE DATA DICTIONARY Date Range: September 1, 1995 to present date, data is provided by calendar year Data Source: BC Ministry of Health Description The PharmaNet system is an online,
More informationSmoking Cessation Program
Guide to Pharmacist Health Coaching Smoking Cessation Program Smoking is the leading cause of preventable death in Canada and a significant risk factor for many chronic non-communicable diseases including
More informationGuidance on standards for training in smoking cessation practice in Wales
Guidance on standards for training in smoking cessation practice in Wales Contents Page 1.0 Introduction 3 1.1 Purpose of this document 1.2 Levels of training for smoking cessation interventions 1.3 Who
More informationTobacco Taxation in New Zealand
Tobacco Taxation in New Zealand A report for the Smokefree Coalition and ASH New Zealand Death and Taxes Seminar Future Directions for Tobacco Taxation 1 Tobacco Taxation in New Zealand A report for the
More information(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT
(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT To amend sections 4723.01, 4723.06, 4723.48, 4723.482, and 4723.50; to amend, for the purpose of adopting new section numbers
More informationRestructure, Redeployment and Redundancy
Restructure, Redeployment and Redundancy Purpose and Scope From time to time the Lake District National Park Authority will need to reorganise its services and staffing to meet changes that arise in future
More informationPharmaPlus at a Glance
PharmaPlus at a Glance A summary of our services to you info@pharmaplusltd.co.uk 0208 863 3335 www.pharmaplusltd.co.uk Dear colleague I would like to introduce you to PharmaPlus, a leading support group
More informationCommunity Pharmacy in 2016/17 and beyond - proposals Stakeholder briefing sessions
Community Pharmacy in 2016/17 and beyond - proposals Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving
More informationCentraCare Health System Creates New Tools to Treat Tobacco Dependence
CentraCare Health System Creates New Tools to Treat Tobacco Dependence Between October 2010 and June 2012, ClearWay Minnesota SM provided the CentraCare Health Foundation with funding and technical assistance
More informationDeveloping a Public Health Skills Passport
Developing a Public Health Skills Passport Claire Cotter and Lauren King October 2014 Outline Why are we developing a Public Health Skills Passport? What is a Skills Passport? What is the aim of the Public
More informationRelevant Previous Documents: Welsh Assembly Government Programme Level Agreement
Stop Smoking Wales Annual Report 2010-2011 Authors: Stop Smoking Wales Editorial Group Date: 15/08/2011 Version: 1 Status: Final Relevant Previous Documents: Welsh Assembly Government Programme Level Agreement
More informationElectronic prescribing
ALL-PARTY PHARMACY GROUP Chair: Dr Howard Stoate MP Vice Chairs: Dr Jenny Tonge MP & Rt Hon Lord Newton of Braintree OBE Treasurer: David Heath CBE MP Secretary: Mark Todd MP Electronic prescribing A report
More informationA breath of fresh air Our vision for smoke-free hospital sites
A breath of fresh air Our vision for smoke-free hospital sites Have your say on our smoke-free vision 1 Our responsibility We are a large acute trust serving a population of 700,000 people, with over 6,000
More informationNHS Whittington Health/ Smokefree Islington <Enter date>
Helping your employees go smokefree NHS Whittington Health/ Smokefree Islington 1. Why smoking matters Why is smoking an important issue? Smoking is the main cause of preventable deaths and
More informationAudit to assess GP awareness and documentation of biologic and DMARD drugs in primary care patient records
Audit to assess GP awareness and documentation of biologic and DMARD drugs in primary care patient records Queen Elizabeth Hospital Gateshead Shekar P, Goodhead C, Kelly C, Francis G, Bailey AM*, Thompson
More informationPOLICY AND PROCEDURE. Alcohol & Drugs. SoLO Life Opportunities. Introduction. Category: staff and volunteers
SoLO Life Opportunities POLICY AND PROCEDURE Alcohol & Drugs 38 Walnut Close Chelmsley Wood Birmingham B37 7PU Charity No. 1102297 England Company No. 5025939 Category: staff and volunteers Introduction
More information8 Pharmacy Fees and Subsidies, and Provider Payment
8 Pharmacy Fees and Subsidies, and Provider Payment 8.1 About Fees and Subsidies... 2 8.2 Dispensing Fees... 3 Patient eligibility... 3 Maximum fee... 3 Who can claim a dispensing fee?... 3 Frequent dispensing...
More informationfinding the balance between public and private health the example of australia
finding the balance between public and private health the example of australia By Zoe McKenzie, Senior Researcher This note provides an overview of the principal elements of Australia s public health system,
More informationUnderstanding Clinical Trials
Understanding Clinical Trials The UK Clinical Research Collaboration (UKCRC) is a partnership of organisations working to establish the UK as a world leader in clinical research, by harnessing the power
More informationSmoking and your lungs Why it s never too late to give up
Smoking and your lungs Why it s never too late to give up Giving up smoking is never easy, but it s the most important thing you can do to look after your health. If you have a lung condition, you might
More informationFebruary 18, 2010. Dear Cessation Program Provider:
February 18, 2010 Dear Cessation Program Provider: The Alabama Department of Public Health (ADPH) is pleased to present this Request for Application (RFA) for online cessation services for the Alabama
More informationCANDIS LEGAL CARE POLICY SUMMARY
Summary of Cover This summary does not contain the full terms and conditions of the Policy, The full terms, conditions and exclusions that apply to the Policy can be found in the Policy document. You have
More informationUCB. Certolizumab pegol (CIMZIA ) for the treatment of Rheumatoid Arthritis PATIENT ACCESS SCHEME (PAS) SUBMISSION TO NICE
UCB Certolizumab pegol (CIMZIA ) for the treatment of Rheumatoid Arthritis PATIENT ACCESS SCHEME (PAS) SUBMISSION TO NICE July 23 d 2009 1 Executive summary UCB have proposed a patient access scheme (PAS)
More informationNBCH Case Studies Introductory Report
NBCH Case Studies Introductory Report Nicotine dependence from smoking is a chronic, relapsing medical condition not just a bad habit that poses a tremendous public health and economic burden on society.
More informationEnsuring Best Practice in the Notification of Prescription Medical Product Discontinuations
Ensuring Best Practice in the Notification of Prescription Medical Product Discontinuations TGA and Medicines Australia Conjoint Best Practice Guidelines October 2007 1 Ensuring Best Practice in the Notification
More informationISSUEBrief. Reducing the Burden of Smoking on Employee Health and Productivity. Center for Prevention
Center for Prevention and Health ISSUEBrief Services Volume I, Number 5 Reducing the Burden of Smoking on Employee Health and Productivity This issue brief summarizes information presented during the fifth
More informationNHS Penalty Charge Guidance
NHS Penalty Charge Guidance Preface The need for the Penalty Charge within the NHS Many people wrongly claim help with health costs, which is costing the NHS millions of pounds each year. We cannot build
More informationUse of electronic cigarettes (vapourisers) among adults in Great Britain
May 2016 Use of electronic cigarettes (vapourisers) among adults in Great Britain 33 Summary of findings An estimated 2.8 million adults in Great Britain currently use electronic cigarettes (vape) up from
More informationEnsuring Best Practice in the Notification of Product Discontinuations
Ensuring Best Practice in the Notification of Product Discontinuations Best Practice Guidelines May 2001 Foreword Discontinuing a medicine is a decision that most pharmaceutical companies will take at
More informationGUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES
GUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES January 2009 Contents Page Number 1.0 Introduction 3 2.0 Background 4 3.0 Criteria 5 3.1 Referral 5 3.2 Levels of assistance/consent
More informationStop Smoking Wales Workplace Tool Kit
Stop Smoking Wales Workplace Tool Kit Suitable for Workplaces with over 50 employees Developed in partnership between Stop Smoking Wales and Healthy Working Wales. Dear An estimated 34 million days a year
More informationInterface between NHS and private treatment Guidance from the Ethics Department February 2004
Interface between NHS and private treatment Guidance from the Ethics Department February 2004 Summary General principles Issues for consultants Issues for general practitioners Advertising Summary Although
More informationSummary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationTAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026)
TAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026) 1. Purpose of the policy The purpose of the Student Alcohol and Other Drug Policy is to
More informationSmoking Cessation: Treatment Options for Nicotine Addiction
Smoking Cessation: Treatment Options for Nicotine Addiction Hilary Nierenberg, NP, MPH Center for Interventional Vascular Therapy Columbia University Medical Center Disclosure Statement of Financial Interest
More informationThe Jobcentre Plus offer for people with drug and/or alcohol dependency
Working with claimants with a drug and/or alcohol dependency Introduction At the heart of the Government s drug and alcohol strategy is a commitment to transform treatment services to offer recovery as
More informationHIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM. Western Australia Administrative Guidelines
HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM Western Australia Administrative Guidelines Pharmaceutical Services Branch Health Protection Group Table of Contents BACKGROUND...1 Overview...1 AHMAC
More informationTHE FUNCTIONS OF CLINICAL COMMISSIONING GROUPS (UPDATED TO REFLECT THE FINAL HEALTH AND SOCIAL CARE ACT 2012)
THE FUNCTIONS OF CLINICAL COMMISSIONING GROUPS (UPDATED TO REFLECT THE FINAL HEALTH AND SOCIAL CARE ACT 2012) DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM
More informationHarold Rogers Prescription Drug Monitoring Program
Harold Rogers Prescription Drug Monitoring Program 19 th National Conference on Pharmaceutical and Chemical Diversion June 16-17, 2010 Harold Rogers Prescription Drug Monitoring Program Since fiscal year
More informationBritish Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among
More informationRULE. The Administration of Medication in Louisiana Public Schools
RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments
More informationCollaborative Drug Therapy
Legislation and regulations affecting pharmacists practice guidelines vary according to the legislative styles and practices of each state. The following information highlights the legislative elements
More informationPharmacy Policy (General)
WORKSAFE VICTORIA Pharmacy Policy (General) WorkSafe can pay the reasonable costs of medications and other pharmacy items required as a result of a work-related injury or illness in accordance with Victorian
More informationPharmacovigilance and the Internet: A Call for Change
Pharmacovigilance and the Internet: A Call for Change A white paper from the ABPI Pharmacovigilance Expert Network 13 June 2011 Page 2 of 6 Pharmacovigilance and the Internet: A Call for Change (ABPI)
More informationSUMMARY OF RESPONSES TO CONSULTATION MLX310
SUMMARY OF RESPONSES TO CONSULTATION MLX310 1. Consultation MLX 310 was issued with a deadline for comments of 29 October. It was circulated to a range of interested organisations throughout the UK and
More informationMedications to help you quit smoking
Medications to help you quit smoking How can medication help me quit smoking? Using medications can increase your chances of quitting smoking 2 to 3 times more than quitting without using medications.
More informationProfessional Standards and Guidance for the Sale and Supply of Medicines
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
More informationCigarettes and Other Tobacco Products
Cigarettes and Other Tobacco Products Tobacco use is the leading preventable cause of disease, disability, and death in the United States. Between 1964 and 2004, cigarette smoking caused an estimated 12
More informationGENERAL PRACTICE BASED PHARMACIST
GENERAL PRACTICE BASED PHARMACIST JOB PURPOSE Provide expertise in clinical medicines review 1 and address public health and social needs of patients in GP practices Reduce inappropriate poly-pharmacy
More informationNo Smoking Policy. 5.0 Final. Deterring Smoking by Staff, Patients and Visitors
No Smoking Policy 5.0 Final Deterring Smoking by Staff, Patients and Visitors EQUALITY IMPACT The Trust strives to ensure equality of opportunity for all both as a major employer and as a provider of health
More informationSTATE POLICY ADVOCACY PRIORITIES. American Academy of Dermatology Association
STATE POLICY ADVOCACY PRIORITIES American Academy of Dermatology Association Access to Pharmaceuticals/Cost Transparency AADA collaborates with manufacturers, the health care community, policymakers, private
More informationGuidance on the Medicines Use Review service
Guidance on the Medicines Use Review service October 2013 Contents 1. Introduction... 2 2. The regulatory framework... 3 3. Conditions to be met by pharmacy contractors.... 4 4. Ongoing conditions for
More informationRESEARCH. Poor Prescriptions. Poverty and Access to Community Health Services. Richard Layte, Anne Nolan and Brian Nolan.
RESEARCH Poor Prescriptions Poverty and Access to Community Health Services Richard Layte, Anne Nolan and Brian Nolan Executive Summary Poor Prescriptions Poor Prescriptions Poverty and Access to Community
More informationFIRST ISSUED: July 1 st 2014. The service specification and the contract agreement will be subject to review annually
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN SHEFFIELD CLINICAL COMMISSIONING GROUP TO SUPPLY NICOTINE REPLACEMENT THERAPY AND VARENICLINE TO CLIENTS OF SHEFFIELD SMOKE FREE SERVICE PREPARED
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationDATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS
Reference Number: UHB 139 Version Number: 2 Date of Next Review: 14 Apr 2018 Previous Trust/LHB Reference Number: N/A DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Introduction and Aim
More informationNew York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee
New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee PICA PRESCRIPTION DRUG PROGRAM Self-Injectable Medications Chemotherapy Medications Questions & Answers Last
More informationGet in on the Act: Children and Families Act 2014. Corporate
Get in on the Act: Children and Families Act 2014 Corporate Get in on the Act: Children and Families Act 2014 Background The Children and Families Bill was introduced in the House of Commons on 4 February
More information1.1 WHAT IS A QUIT LINE?
1.Benefits and rationale for establishing quit-line services 1.1 WHAT IS A QUIT LINE? Quit lines provide a variety of tobacco cessation services predominately via telephones. These usually include: initial
More informationCommissioning Policy. Defining the boundaries between NHS and Private Healthcare
Commissioning Policy Defining the boundaries between NHS and Private Healthcare Reference No: Version: 1 Ratified by: PH007 East Midlands Specialised Commissioning Group Board (EMSCG) June 2009 Date ratified:
More informationAbout one-half of all smokers die of a disease caused by smoking.the most common ones are lung cancer, heart disease, and strokes
Patient information from the BMJ Group Stopping smoking Smoking harms your health, but it's difficult to stop. That s because most people who smoke have become addicted to nicotine, a chemical in tobacco.
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Lisa Musielewicz S.B. 228 129th General Assembly (As Introduced) Sens. Burke, Lehner, Schiavoni, Tavares, Schaffer BILL SUMMARY Authorizes a certified
More informationA Working Paper from the Resilience project in the Centre for Health Policy and Management, School of Medicine, Trinity College Dublin
A Working Paper from the Resilience project in the Centre for Health Policy and Management, School of Medicine, Trinity College Dublin Measuring, Mapping and Making Sense of Irish Health System Performance
More informationQuitNow Stop Smoking Medication Guide. Quitting Resources
QuitNow Stop Smoking Medication Guide Quitting Resources QUITNOW STOP SMOKING MEDICATION GUIDE Table of Contents page Intro 2 The B.C. Smoking Cessation Program 2 Nicotine Patches 3 5 Nicotine Gum 6 7
More informationGUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2
SH CP 29 GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Summary: Guidelines for the use of paliperidone palmitate (Xeplion ) Keywords (minimum of 5): (To assist policy search engine) Target
More informationGP/Family doctor Hospitals. Medicine and pharmacy. Dentist. Health. The Danish Healthy Cities Network
Health GP/Family doctor Hospitals Dentist The Danish Healthy Cities Network Medicine and pharmacy Health Health Care in Denmark The Danish health care service covers many different institutions and functions
More informationFunds in the Cayman Islands Investment Fund Regulation
Funds in the Cayman Islands Investment Fund Regulation The law is simple and straightforward. Not all investment funds are regulated under the law. Not required to be registered are close ended funds (i.e.
More informationNurse practitioners in major accident and emergency departments: a national survey
Journal of Accident and Emergency Medicine 1995, 12,177-181 Nurse practitioners in major accident and emergency departments: a national survey S.J. MEEK, G. RUFFLES, J. ANDERSON & D. OHIORENOYA Accident
More informationOccupational pension scheme governance
GfK. Growth from Knowledge Occupational pension scheme governance A report on the 2014 (eighth) scheme governance survey Prepared for: The Pensions Regulator By: GfK Financial, May 2014 1 P a g e Contents
More informationInvitation to Tender. Policy Research Programme: Evaluation of the New Medicines Service
Invitation to Tender Policy Research Programme: Evaluation of the New Medicines Service 1. The New Medicines Service (NMS) is being developed to improve the adherence to newly prescribed medicines by people
More informationSHEFFIELD CITY COUNCIL
FORM 2 SHEFFIELD CITY COUNCIL Non Key Officer Report Report of: Transport Planning Manager Report to: Moaz Khan, Interim Head of Transport, Traffic and Parking Services Date: 10/04/2015 Subject: Worst
More informationStandards of Practice for Pharmacists and Pharmacy Technicians
Standards of Practice for Pharmacists and Pharmacy Technicians Introduction These standards are made under the authority of Section 133 of the Health Professions Act. They are one component of the law
More informationA Review of Access to North Somerset NHS Dental Services May 2015
A Review of Access to North Somerset NHS Dental Services May 2015 Background One of the key issues that people in North Somerset discuss with Healthwatch North Somerset is difficulties experienced accessing
More information